Herpes zoster: Risk and prevention during immunomodulating therapy.
Joint Bone Spine
; 84(1): 21-27, 2017 Jan.
Article
in En
| MEDLINE
| ID: mdl-27245419
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Rheumatic Diseases
/
Herpes Zoster Vaccine
/
Immunomodulation
/
Herpes Zoster
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Joint Bone Spine
Journal subject:
REUMATOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: